Suche
-
Markteroberung mit innovativer Technologie
Neuer Bericht über die wachsende Healthcare Industrie in Asien. Effektives Kostenmanagement und die Einführung moderner Spitzentechnologie – diese beiden Hauptvoraussetzungen müssen medizinische Unternehmen für eine marktführende Position auf dem südostasiatischen Healthcare-Markt erfüllen. Dies ist das Ergebnis eines aktuellen Berichts von Ipsos Business Consulting über die Healthcare-Branche der ASEAN-Staaten.
-
Global Obesity Study on Drivers for Weight Reduction Strategies
To assess factors determining the reaction of individuals to the threats of overweight and obesity and to examine the interdependencies between weight-reducing strategies.
-
The Ipsos “New Way”
The turnover of Ipsos has been flat for the past three years. Based on this disappointing fact, the management of Ipsos has launched a programme designed to foster a route to profitable growth.
-
Ipsos announces the death of Jean Marc Lech, Ipsos Co-President
It is with deep sadness that we announce the death of Jean-Marc Lech, Ipsos Co-President, this morning in Paris. Jean-Marc Lech, a sociologist and philosopher by training, started his career in 1970 at the Institut Français d’Opinion Publique where he became CEO in 1980. In 1982, he joined Ipsos as Co-President alongside Didier Truchot, the company’s founder.
-
Oncology: The Disease, the Dynamics and the Difficulties of Global Marketing Research
The World Health Organisation estimates that the incidence of cancer could increase by 50% to 15 million cases by the year 2020. To put that into context, that is nearly the entire population of the Netherlands. Each and every one of us will likely be impacted by cancer in some way during our lifetime. Whether we experience the disease personally or know someone who has, cancer is a disease that we are all vaguely familiar with. Cancer was first discovered over 3,000 years ago and yet in some ways, it is as much a mystery today as it was then. While we have learned more about the causes and effective treatments, those who work in the oncology market are constantly faced with the challenges of this everchanging disease.